Global Peptides and Heparin Market Revenue are Estimated to Exceed US$ 34,000 Mn by 2026-End.

Fact.MR Fact.MR

Dublin 2, Ireland, 2018-Feb-22 — /EPR Network/ — Growth of the global peptide and heparin market is expected to remain affected by key factors such as rising prevalence of chronic ailments, alleviated demand for effective drugs & technology, new product developments, and rising investments by leading market players in R&D activities. This Fact.MR report analyzes the expansion of global peptide and heparin market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=378

Drug Developers Shifting Back to Peptides owing to Mounting Challenges regarding Small Molecules

While the pharmaceutical sector discerned small molecules as the medicinal agents, therapeutic peptides were considered to be niche products. However, with mounting challenges regarding small molecules, drug developers are shifting their concentration back to small amino acid chains. Although peptides have been deemed ineffective for developing drugs, modern peptide drug designs and formulations have been developed for circumventing their weaknesses. For example, original requirement for injecting peptides such as insulin is fading, with more patient-friendly administrations progressively being developed. In addition, the current society that critically judges undesirable effects and environmental impact of the candidate medicines is embracing the safety offered by peptides.

A new report by Fact.MR projects the global market for peptide and heparin to reflect an impressive expansion during the forecast period, 2017 to 2026. Revenues from the market are estimated to exceed US$ 34,000 Mn by 2026-end.

APEJ to Remain Most Remunerative Market for Peptide and Heparin

There has been a growing demand for new oral anticoagulants having better efficacy and safety profiles in Asia-Pacific excluding Japan (APEJ). Side effects related to heparin products, including complications of bleeding and heparin-induced thrombocytopenia has resulted into robust adoption of oral anticoagulants in the region. In addition, rising incidence of cancer, metabolic disorders, and hepatitis, along with advancements in peptide synthesis technology and rapid demand for various peptide therapies in the region are expected to drive the growth in APEJ. APEJ will remain the most remunerative market for peptide and heparin.

Liraglutide and ammonium heparin are expected to remain fast-expanding products in the market. In addition, sales of exenatide, lithium heparin, and sodium heparin will register a similar CAGR through 2026.

Key Research Findings from Fact.MR’s Report on Peptide and Heparin Market

Oral route of administration will remain preferred for peptide and heparin

Cancer will continue to be the dominant indication segment in the market, in terms of revenues

Hospital pharmacies will remain the most lucrative distribution channel for peptide and heparin

Competition Tracking

The global market for peptide and heparin is high fragmented and competitive owing to the presence of a large number of international and regional vendors. These vendors are continuously focusing on the development of generic formulations related to blood coagulation and several other novel therapeutic areas. Companies having the capability of manufacturing drugs for effective treatment of coagulation disorders, along with high efficacy and safety profiles are likely to gain maximum market shares in the foreseeable future. Key market participants identified by the report include Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm, Inc., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., Bachem, Abbott Laboratories, Pfizer Inc., Aspen, Leo Pharma, Teva, Takeda, Sanofi, Novo Nordisk, and Eli Lilly.

Browse Full Report With TOC- https://www.factmr.com/report/378/peptides-heparin-market

Table of Content

  1. Global Economic Outlook
  2. Global Peptide and Heparin Market – Executive Summary
  3. Global Peptide and Heparin Market Overview
    3.1. Introduction
    3.1.1. Global Peptide and Heparin Market Taxonomy
    3.1.2. Global Peptide and Heparin Market Definition
    3.2. Global Peptide and Heparin Market Size (US$ Mn) and Forecast, 2012-2026
    3.2.1. Global Peptide and Heparin Market Y-o-Y Growth
    3.3. Global Peptide and Heparin Market Dynamics
    3.4. Supply Chain
    3.5. Cost Structure
    3.6. PESTLE Analysis
    3.7. Product Lifecycle
    3.8. List of Distributors
    3.9. Key Participants Market Presence (Intensity Map) By Region
  4. Global Peptide and Heparin Market Analysis and Forecast 2012-2026 
    4.1. Global Peptide and Heparin Market Size and Forecast By Product Type , 2012-2026
    4.1.1. Sodium Heparin Market Size and Forecast, 2012-2026
    4.1.1.1. Revenue (US$ Mn) Comparison, By Region
    4.1.1.2. Market Share Comparison, By Region
    4.1.1.3. Y-o-Y growth Comparison, By Region
    4.1.2. Ammonium Heparin Market Size and Forecast, 2012-2026
    4.1.2.1. Revenue (US$ Mn) Comparison, By Region
    4.1.2.2. Market Share Comparison, By Region
    4.1.2.3. Y-o-Y growth Comparison, By Region
    4.1.3. lithium Heparin Market Size and Forecast, 2012-2026
    4.1.3.1. Revenue (US$ Mn) Comparison, By Region
    4.1.3.2. Market Share Comparison, By Region
    4.1.3.3. Y-o-Y growth Comparison, By Region
    4.1.4. Icatibant Market Size and Forecast, 2012-2026
    4.1.4.1. Revenue (US$ Mn) Comparison, By Region
    4.1.4.2. Market Share Comparison, By Region
    4.1.4.3. Y-o-Y growth Comparison, By Region

Continue…..

Request For Discount On This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=378

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

Matched content

Editor’s pick

Express Press Release Distribution